CN Bio has been awarded an Innovate UK Grant to reduce animal use in pharmacokinetic studies. The funding will support the development of a standardised workflow to integrate advanced dual organ PhysioMimix® Gut/Liver data with powerful PBPK in silico modelling: bit.ly/3RP08GJ

Calla Lily Clinical Care announces it has joined Wellcome Leap's $50M Focused Antibiotics programme addressing the growing global threat of antibiotic-driven antimicrobial resistance #AMR: shorturl.at/QiCda

Broken String Biosciences launches BaseMap ABE, expanding the capabilities of the Company's INDUCE-seq platform for genome-wide characterisation of off-target events in adenine base editing (ABE) workflows. Read the full press release: bit.ly/4fQiReg

DNA Script in collaboration with prime awardee GE HealthCare, has been awarded up to $26 million in funding for a four-year initiative from the Advanced Research Projects Agency for Health (ARPA-H). Learn more: shorturl.at/kfkEy

Today Qureight announced it has closed $20 million in a Series B financing, which will support further development of the Company’s 3D deep leaning imaging portfolio and enable commercial expansion as Qureight continues to address demand in lung and heart diseases. bit.ly/4x7g06f

Carterra has been named as a core enabler of the $7B Lab-in-the-Loop Antibody Discovery Market in a Leerink Partners report, which highlights how the Company’s high-throughput surface plasmon resonance platforms are supporting the expanding market of AI-driven biologics discovery: bit.ly/45uI9Z2

SynGenSys announced the expansion of its senior commercial and scientific teams with the appointments of several heads of departments, supporting the company’s commercial scale-up. Read more: shorturl.at/4q4UO

FairJourney Bio has announced the scientific program and leadership for The Antibody Series 2026. To register interest in attending or to receive early access to on-demand lectures and session recordings, visit: rebrand.ly/uqowaas. Read more here: rebrand.ly/ilj6pcc

Today, EpilepsyGTx announced the appointment of Dr Teresa Nunes as Chief Medical Officer. With expertise spanning CGTs and the CNS, Teresa will steer the Company’s lead gene therapy programme for focal refractory epilepsy, EPY201, through clinical trials: shorturl.at/RZBix

DNA Script announced a new distribution agreement with Imperial Life Sciences, expanding access to the Company's SYNTAX® platform for in-house DNA synthesis capabilities across India ➡️ shorturl.at/fSjif

EpilepsyGTx and @clearpointneuro.bsky.social have partnered to support delivery of EpilepsyGTx’s lead gene therapy candidate, EPY201, for focal refractory epilepsy, ensuring precise administration to the seizure focus in upcoming Phase 1/2a clinical trials: tinyurl.com/v4evhju5

Camena Bioscience has appointed Gregory P. McGuiness as CEO. Greg's appointment will support the Company’s continued growth, driving commercialisation of the gSynth® platform for AI-driven antibody discovery, and operational scaling. Read more here: rebrand.ly/yxn63er

Bio-Rad Laboratories today announced the launch of Vericheck ddPCR™ Kits compatible with the QX700 platform for critical quality control workflows in advanced cell and gene therapy development and other biopharma applications. Read more here: rebrand.ly/hdn2w2n

Today, Eppendorf announced its latest outreach programmes to advance STEM education in Europe. The Company is inspiring the next generation of scientists by hosting students at its HQ, providing hands-on experience, and donating instruments to schools: bit.ly/4y9PHOb

Today Exonate announced the appointment of Olav Hellebø as its new CEO to lead the company toward key clinical and corporate milestones. Read more: www.exonate.com/updates/exon...

FairJourney Bio has entered a partnership with AbTherx to bring transgenic mouse-based antibody discovery in-house, enabling partner programmes to run from immunisation to a developability-assessed lead in one continuous workflow. Read more here: rebrand.ly/pb4lgxv

OMED Health, part of Owlstone Medical, and Welbeck Health Partners, one of the UK's largest specialist outpatient healthcare providers, announced that Welbeck has adopted OMED Health's home-based Small Intestinal Bacterial Overgrowth (SIBO) breath-testing pathway ➡️ shorturl.at/i4ZeP

Tecan announce the integration of Agentic AI capabilities into its lab analytics platform Introspect. Leveraging NVIDIA BioNeMo Agent Toolkit enables AI agents to access AI capabilities directly within the Introspect platform, helping laboratories to optimize operations:https://shorturl.at/AAYNC

@trimtechtx.bsky.social announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million to progress its targeted protein degradation portfolio ➡️ trimtechtherapeutics.com/trimtech-the...

Today, Broken String Biosciences announced the appointment of Dr Bruce Eaton as Chairman of the Board. With 30+ years' biotech experience and responsible for 80+ patents, Bruce will support operational scaleup and global commercial expansion for INDUCE-seq: www.brokenstringbio.com/news/broken-...

Laverock Therapeutics today reported key in vivo functional research milestones across its T-cell and macrophage oncology programmes for solid tumour indications. Read the full press release here: lnkd.in/eWUdD3uS

Today PhoreMost announced its lead oncology programme PMC-001, a small molecule microtubule targeting agent (MTA) for primary and secondary brain cancers and the appointment of Dr Gabriel Fox as CMO to lead its clinical development ➡️https://shorturl.at/i6amG

LotusDx this week announced it has established its R&D laboratory at ONE BioHub in Aberdeen. The move marks a key milestone in the Company’s ongoing development of its portfolio of at-home STI testing kits. Read more here: rebrand.ly/d77xhay

Bio-Rad Laboratories has received MicroVal validation for its EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Kits. The kits deliver streamlined workflows with rapid time to result, enabling accurate detection of Listeria in food and environmental samples: tinyurl.com/23223ft8

Laverock Therapeutics has been awarded in excess of £2.2M in innovation grants to support the next generation of its AI-powered gene-control platform development, and expansion into additional non-oncology therapeutics areas: shorturl.at/Mydkb

SLAS has announced the award winners of this years’ annual European conference, which took place last week in Vienna. Read the full release here: bit.ly/4vi1U19

Combat Medical today announced an update on its HIVEC® HEAT Phase 3 clinical trial presented at the American Urological Association Annual Meeting, outlining the study design and recruitment process ➡️ rebrand.ly/gm4og2j

OutSee has been selected for a Discovery Award from the Longitude Prize on ALS, funding new research to uncover novel therapeutic targets for ALS using OutSee’s proprietary ‘genomics first’ platform, Nomaly. Read the full press release: bit.ly/43eWEPF

Cyclana Bio today announced it has received HRA and REC approval for its clinical observational study in endometriosis. The first patients have been recruited at Peterborough City Hospital, with the Rosie Hospital, Cambridge recently also starting recruitment. Read more here: rebrand.ly/a9373br

Qureight and Mediar Therapeutics today announced Qureight's AI-powered 3D quantitative imaging analytics platform and services will be used in Mediar's Phase 2 EncompaSSc clinical trial to support evaluation of MTX-474 in diffuse cutaneous Systemic Sclerosis. Read more here: bit.ly/3R4U9Nc